CMPS logo
CMPS NASDAQ GB

COMPASS Pathways Plc - American Depository Shares

Healthcare · Biotechnology Website · IPO Sep 2020
$5.79
▲ +$0.17 (+3.02%)
Vol 1.3M
2
Quality Score
fail
Mkt Cap
$662.4M
ROE
-172.5%
D/E
83.18
Beta
1.96
52W
$2–$7

Wall Street Consensus

18 analysts · Apr 2026
5
Strong Buy
11
Buy
2
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

About COMPASS Pathways Plc - American Depository Shares

Компанія Compass Pathways (CMPS) - біотехнологічна компанія, що займається розробкою психіатричних препаратів на основі псилоцибіну для лікування депресії. Вони є лідерами у цій галузі, зосереджуючись на клінічних випробуваннях та отриманні регуляторних дозволів. Їх конкурентна перевага полягає в новаторському підході та активній співпраці з регуляторними органами.

Earnings

Beat rate: 60.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.40 $-1.00 $-0.60
Sep 2025 $-0.40 $-1.44 $-1.04
Jun 2025 $-0.44 $-0.41 +$0.03
Mar 2025 $-0.48 $-0.38 +$0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -78.6% -78.2% -78.6% -78.6% -172.5% -172.5%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 19.03 19.02 19.03 19.03 83.18 83.18
Current Ratio 8.82 8.90 8.82 8.82 1.23 1.23

Key Ratios

ROA (TTM)
-87.7%
P/B
1.7
EPS (TTM)
$-2.68
CF/Share
$-2.58
52W High
$7.15
52W Low
$2.25
$2.25 52-Week Range $7.15

How does CMPS compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CMPS AAPG ABEO ABOS ABP

CMPS valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.7
32% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CMPS profitability vs Biotechnology peers

ROE
-172.5%
156% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-87.7%
88% below peers (-46.7%)
vs Peers
vs Industry
Weak

CMPS financial health vs Biotechnology peers

D/E ratio
83.2
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.2
72% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.0
103% above peers (1.0)
vs Peers
vs Industry
More volatile

CMPS fundamentals radar

CMPS Peer median Industry

CMPS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CMPS vs peers: key metrics

Latest News

No related news yet